ATE135044T1 - Faktor x-laci-hybridprotein - Google Patents

Faktor x-laci-hybridprotein

Info

Publication number
ATE135044T1
ATE135044T1 AT91870008T AT91870008T ATE135044T1 AT E135044 T1 ATE135044 T1 AT E135044T1 AT 91870008 T AT91870008 T AT 91870008T AT 91870008 T AT91870008 T AT 91870008T AT E135044 T1 ATE135044 T1 AT E135044T1
Authority
AT
Austria
Prior art keywords
laci
factor
hybrid protein
amino acid
acid sequence
Prior art date
Application number
AT91870008T
Other languages
English (en)
Inventor
Thomas James Girard
George John Broze Jr
Original Assignee
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Washington filed Critical Univ Washington
Application granted granted Critical
Publication of ATE135044T1 publication Critical patent/ATE135044T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6432—Coagulation factor Xa (3.4.21.6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114—Kunitz type inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21006—Coagulation factor Xa (3.4.21.6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT91870008T 1990-01-25 1991-01-21 Faktor x-laci-hybridprotein ATE135044T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47028990A 1990-01-25 1990-01-25

Publications (1)

Publication Number Publication Date
ATE135044T1 true ATE135044T1 (de) 1996-03-15

Family

ID=23866994

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91870008T ATE135044T1 (de) 1990-01-25 1991-01-21 Faktor x-laci-hybridprotein

Country Status (8)

Country Link
EP (1) EP0439442B1 (de)
JP (1) JP2560150B2 (de)
AT (1) ATE135044T1 (de)
CA (1) CA2034881C (de)
DE (1) DE69117545T2 (de)
DK (1) DK0439442T3 (de)
ES (1) ES2086521T3 (de)
GR (1) GR3019877T3 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT98779B (pt) * 1990-08-27 1999-06-30 Monsanto Co Processo para a preparacao de uma composicao anticoagulante contendo inibidor sulfatados e metodos para a sua utilizacao
US5276015A (en) * 1992-03-18 1994-01-04 Washington University Method of inhibiting microvascular thrombosis
WO1994007528A1 (en) * 1992-09-25 1994-04-14 Corvas International, Inc. Bovine pancreatic trypsin inhibitor derived inhibitors of factor viia-tissue factor complex
US5863894A (en) * 1995-06-05 1999-01-26 Corvas International, Inc. Nematode-extracted anticoagulant protein
US5872098A (en) * 1995-06-05 1999-02-16 Corvas International, Inc. Nematode-extracted anticoagulant protein
US5866542A (en) * 1994-10-18 1999-02-02 Corvas International, Inc. Nematode-extracted anticoagulant protein
US5945275A (en) * 1994-10-18 1999-08-31 Corvas International, Inc. Nematode-extracted anticoagulant protein
US5866543A (en) * 1995-06-05 1999-02-02 Corvas International, Inc. Nematode-extracted anticoagulant protein
HU225126B1 (en) * 1994-10-18 2006-06-28 Dendreon Corp Nematode-extracted serine protease inhibitors and anticoagulant proteins
CA2202351A1 (en) * 1994-10-18 1996-04-25 George Phillip Vlasuk Nematode-extracted serine protease inhibitors and anticoagulant proteins
US5772629A (en) * 1995-10-23 1998-06-30 Localmed, Inc. Localized intravascular delivery of TFPI for inhibition of restenosis in recanalized blood vessels
US5910481A (en) * 1995-11-13 1999-06-08 Immuno Ag Hybrid proteins with modified activity
US5736364A (en) * 1995-12-04 1998-04-07 Genentech, Inc. Factor viia inhibitors
EP0866870B1 (de) * 1995-12-01 2003-03-12 Genentech, Inc. Fusionsproteine bestehend aus gewebefaktor-kunitzdomäne als inhibitoren des faktors viia
WO1997033996A2 (en) 1996-03-11 1997-09-18 Bayer Corporation Human bikunin
US6159722A (en) 1997-12-03 2000-12-12 Boehringer Mannheim Gmbh Chimeric serine proteases
EP0927764B1 (de) * 1997-12-03 2004-05-26 Boehringer Mannheim Gmbh Chimäre Serinproteasen
AU2001259063A1 (en) * 2000-04-12 2001-10-30 Human Genome Sciences, Inc. Albumin fusion proteins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL87171A (en) * 1987-11-23 1995-08-31 Monsanto Co ANDC of human tissue factor inhibitor

Also Published As

Publication number Publication date
ES2086521T3 (es) 1996-07-01
CA2034881C (en) 2001-05-29
GR3019877T3 (en) 1996-08-31
JP2560150B2 (ja) 1996-12-04
DE69117545T2 (de) 1996-10-31
DE69117545D1 (de) 1996-04-11
DK0439442T3 (da) 1996-07-08
EP0439442A3 (en) 1992-05-27
CA2034881A1 (en) 1991-07-26
EP0439442A2 (de) 1991-07-31
EP0439442B1 (de) 1996-03-06
JPH04211000A (ja) 1992-08-03

Similar Documents

Publication Publication Date Title
DK0439442T3 (da) Faktor X-LACI-hybridprotein
ATE200783T1 (de) Neuartige peptidderivate
ES2031806T3 (es) Factor de permeabilidad vascular humano.
DE68923819D1 (de) Verwendung von gamma-Hydroxy-Buttersäuresalzen zur Herstellung von pharmazeutischen Zusammensetzungen zur Verwendung bei der Behandlung von Alkoholismus und die hergestellten Zusammensetzungen.
ATE81503T1 (de) N-(mercaptoalkyl)-omega-hydroxyalkylamide und ihre verwendung als reduktionsmittel in einem verfahren zur bleibenden gestaltung von haaren.
FI883487A (fi) Ihmisen kudostekijäinhibiittorin DNA-klooni
DK0625912T3 (da) Behandling af inflammatorisk tarmsygdom
ES551820A0 (es) Un procedimiento para la fabricacion de derivados peptidicos inhibidores de la renina y de las proteasas acidas
SE8901552D0 (sv) Acid addition salts of amidated or glycine, their preparation and use
ATE84716T1 (de) 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelialgewebekrankheiten.
DK627687D0 (da) Hirudinvariant
PT88383A (pt) Verfahren fuer die herstellung von 2-[4-<2-(4-chlorbenzamido)-ethyl-phenoxy]-2-methylpropionsaeure enthaltenden pharmazeutischen zusammensetzungen zur behandlung von diabetes geeignet
BG97123A (bg) Производни на човешка, стимулирана от жлъчните соли, липаза и фармацевтични състави на тяхна основа
FI925696A (fi) Pao hirudinets aminosyrasekvens baserade trombininhibitorer
ATE151996T1 (de) Kit zur einführung eines fremdkörpers, der geeignet zur identifikation eines tieres ist
MX9205978A (es) Nuevas proteinas inhibidoras de trombina de garrapatas.
DK366380A (da) Anvendelsen af grp og salte deraf
DK53290A (da) Syntetiske gaer-leader-peptider
DK288581A (da) Anvendelse af peptider som diagnost ikum

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee